Established Investigator and New Faculty Grants
Funding Amount
Not stated
Deadline
Expected ~December
Based on past cycles
Grant Type
Foundation
Deadline history & next window
- Cycle
- Rolling — applications accepted year-round
- Current deadline
- December 31, 2027
- Tracked since
- April 2026
From the program guidelines: “Review of applications conducted on a rolling basis through Fall 2026”
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Established Investigators
Other requirements
- New Faculty members
- Scientists who have not previously worked on scleroderma, as well as those with substantial ongoing scleroderma-focused effort
Not eligible / not funded
- Not eligible: Funding support from the SRF may not be used for administrative overhead, indirect expenses, or other institutional charges (with few exceptions)
- Not eligible: Contact: grants@srfcure.org
- Not eligible: Background: The SRF is America's largest nonprofit investor in scleroderma research and devotes a greater percentage of its annual budget to scleroderma research than any other nonprofit organization.
Overview
Geographic Scope: United States
Focus Areas:
- Understanding the molecular pathogenesis of scleroderma
- New interventions in scleroderma research
- Hypothesis-driven, innovative therapeutic approaches
Eligibility:
- Established Investigators
- New Faculty members
- Scientists who have not previously worked on scleroderma, as well as those with substantial ongoing scleroderma-focused effort
Funding Restrictions:
- Funding support from the SRF may not be used for administrative overhead, indirect expenses, or other institutional charges (with few exceptions)
Background: The SRF is America's largest nonprofit investor in scleroderma research and devotes a greater percentage of its annual budget to scleroderma research than any other nonprofit organization.
How to Apply
Application Process
Timeline:
- 2026 cycle deadline: March 31, 2026 (CLOSED)
- 2027 cycle applications will be available by the end of 2026 or early 2027
- Review of applications conducted on a rolling basis through Fall 2026
- Funding awarded between July – December 2026
Application Guidelines:
- See "Application Guidelines" link on website for detailed requirements
- Multiple funding mechanisms tailored to projects of varying scope
Contact for Questions: grants@srfcure.org
What Scleroderma Research Foundation actually gave
Source: IRS Form 990, 2025
- Grants in 2025
- 26
- Total given
- $3.77M
- Median grant
- $112K
- Range
- $11K–$467K
- By dollars: California 33%, New York 11%, Pennsylvania 11%. Top recipient cities: New York, NY; San Francisco, CA; Dallas, TX.
- 0% of grants with a stated purpose were for general or operating support.
- 8% of recipients were new grantees, not repeat recipients.
Example grants
Regents of Univ of CA-UCSF · San Francisco, CA
Research
$467K
Stanford School of Medicine · San Francisco, CA
Research
$460K
University of Utah · Salt Lake City, UT
Research
$366K
Univ of TX Health Science Ctr · Dallas, TX
Research
$314K
Regents of Univ of Michigan · Pittsburgh, PA
Research
$218K
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
DoW Toxic Exposures Investigator Initiated Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$2,400,000 total
Deadline
November 19, 2026
DoW Orthopaedic, Clinical Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$13,600,000 total
Deadline
November 18, 2026
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
National Institutes of Health
Amount
Varies
Deadline
November 19, 2026
DoW Toxic Exposures Translational Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$6,000,000 total
Deadline
November 19, 2026
DoW Toxic Exposures Clinical Trial Award
Defense Health Agency Contracting Activity - DHACA
Amount
$4,500,000 total
Deadline
November 19, 2026
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
National Institutes of Health
Amount
Up to $375,000
Deadline
November 23, 2026
Ready to apply for Established Investigator and New Faculty Grants?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Established Investigator and New Faculty Grants. Now let's win it.